499 related articles for article (PubMed ID: 22217548)
41. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
[TBL] [Abstract][Full Text] [Related]
42. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
[TBL] [Abstract][Full Text] [Related]
43. O(6)-methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke.
Christmann M; Kaina B
Mutat Res; 2012 Aug; 736(1-2):64-74. PubMed ID: 21708177
[TBL] [Abstract][Full Text] [Related]
44. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways.
Hutt JA; Vuillemenot BR; Barr EB; Grimes MJ; Hahn FF; Hobbs CH; March TH; Gigliotti AP; Seilkop SK; Finch GL; Mauderly JL; Belinsky SA
Carcinogenesis; 2005 Nov; 26(11):1999-2009. PubMed ID: 15944214
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
46. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
47. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
48. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
49. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
Hoffmann AC; Kaifi JT; Vallböhmer D; Yekebas E; Grimminger P; Leers JM; Izbicki JR; Hölscher AH; Schneider PM; Metzger R; Brabender J
J Surg Oncol; 2009 Oct; 100(5):414-7. PubMed ID: 19653236
[TBL] [Abstract][Full Text] [Related]
50. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
[TBL] [Abstract][Full Text] [Related]
51. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
52. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
[TBL] [Abstract][Full Text] [Related]
53. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer.
Kraunz KS; Nelson HH; Lemos M; Godleski JJ; Wiencke JK; Kelsey KT
Int J Cancer; 2006 Mar; 118(6):1364-9. PubMed ID: 16184554
[TBL] [Abstract][Full Text] [Related]
54. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P
Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078
[TBL] [Abstract][Full Text] [Related]
55. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
56. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.
Russo AL; Thiagalingam A; Pan H; Califano J; Cheng KH; Ponte JF; Chinnappan D; Nemani P; Sidransky D; Thiagalingam S
Clin Cancer Res; 2005 Apr; 11(7):2466-70. PubMed ID: 15814621
[TBL] [Abstract][Full Text] [Related]
57. p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos.
Andujar P; Wang J; Descatha A; Galateau-Sallé F; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Renier A; Zucman-Rossi J; Pairon JC; Jaurand MC
Lung Cancer; 2010 Jan; 67(1):23-30. PubMed ID: 19375815
[TBL] [Abstract][Full Text] [Related]
58. Gene promoter methylation in plasma and sputum increases with lung cancer risk.
Belinsky SA; Klinge DM; Dekker JD; Smith MW; Bocklage TJ; Gilliland FD; Crowell RE; Karp DD; Stidley CA; Picchi MA
Clin Cancer Res; 2005 Sep; 11(18):6505-11. PubMed ID: 16166426
[TBL] [Abstract][Full Text] [Related]
59. Aberrant gene promoter methylation of E-cadherin, p16
Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
[TBL] [Abstract][Full Text] [Related]
60. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
